| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials
|
Rafii, Michael S.
|
|
|
34 |
8 |
p. 785-794
|
artikel
|
| 2 |
A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects
|
Fossler, Michael J.
|
|
|
34 |
8 |
p. 853-865
|
artikel
|
| 3 |
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
|
Perucca, Emilio
|
|
|
34 |
8 |
p. 795-800
|
artikel
|
| 4 |
Methadone for Pain Management: A Pharmacotherapeutic Review
|
Kreutzwiser, Denise
|
|
|
34 |
8 |
p. 827-839
|
artikel
|
| 5 |
Newer Formulations of Risperidone: Role in the Management of Psychotic Disorders
|
Clark, Ivana
|
|
|
34 |
8 |
p. 841-852
|
artikel
|
| 6 |
Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design
|
Wu, Min
|
|
|
34 |
8 |
p. 867-877
|
artikel
|
| 7 |
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review
|
Willems, Laurent M.
|
|
|
34 |
8 |
p. 801-826
|
artikel
|
Tijdschrift beschrijving